Steven D Nathan

Steven D Nathan

UNVERIFIED PROFILE

Are you Steven D Nathan?   Register this Author

Register author
Steven D Nathan

Steven D Nathan

Publications by authors named "Steven D Nathan"

Are you Steven D Nathan?   Register this Author

100Publications

2462Reads

35Profile Views

FVC variability in patients with IPF and role of 6-min walk test to predict further change.

Eur Respir J 2020 Feb 6. Epub 2020 Feb 6.

Genentech, Inc., South San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02151-2019DOI Listing
February 2020

Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. Echoes of the Past, Lessons for the Future.

Authors:
Steven D Nathan

Am J Respir Crit Care Med 2019 Dec;200(12):1459-1461

Advanced Lung Disease and Lung Transplant ProgramInova Fairfax HospitalFalls Church, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201908-1510EDDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909842PMC
December 2019

Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients.

Transpl Infect Dis 2019 Dec 18;21(6):e13166. Epub 2019 Sep 18.

Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.13166DOI Listing
December 2019

Multimodal noninvasive prediction of pulmonary hypertension in IPF.

Clin Respir J 2019 Sep 30;13(9):567-573. Epub 2019 Jul 30.

Lung Transplant and Advanced Lung Disease Program, INOVA Fairfax Hospital, Falls Church, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/crj.13059DOI Listing
September 2019

Pulmonary hypertension due to interstitial lung disease.

Curr Opin Pulm Med 2019 Sep;25(5):459-467

Inova Fairfax Advanced Lung Disease and Transplant Clinic, Falls Church, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000599DOI Listing
September 2019

Contemporary optimized practice in the management of pulmonary sarcoidosis.

Ther Adv Respir Dis 2019 Jan-Dec;13:1753466619868935

Inova Fairfax Hospital, 3300 Gallows Rd, Falls Church, VA 22042-3300, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753466619868935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696842PMC
August 2019

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Authors:
Camille Moore Rachel Z Blumhagen Ivana V Yang Avram Walts Julie Powers Tarik Walker Makenna Bishop Pamela Russell Brian Vestal Jonathan Cardwell Cheryl R Markin Susan K Mathai Marvin I Schwarz Mark P Steele Joyce Lee Kevin K Brown James E Loyd James D Crapo Edwin K Silverman Michael H Cho Judith A James Joel M Guthridge Joy D Cogan Jonathan A Kropski Jeffrey J Swigris Carol Bair Dong Soon Kim Wonjun Ji Hocheol Kim Jin Woo Song Lisa A Maier Karin A Pacheco Nikhil Hirani Azin S Poon Feng Li R Gisli Jenkins Rebecca Braybrooke Gauri Saini Toby M Maher Philip L Molyneaux Peter Saunders Yingze Zhang Kevin F Gibson Daniel J Kass Mauricio Rojas John Sembrat Paul J Wolters Harold R Collard John S Sundy Thomas O'Riordan Mary E Strek Imre Noth Shwu-Fan Ma Mary K Porteous Maryl E Kreider Namrata B Patel Yoshikazu Inoue Masaki Hirose Toru Arai Shinobu Akagawa Oliver Eickelberg Isis Enlil Fernandez Jürgen Behr Nesrin Mogulkoc Tamera J Corte Ian Glaspole Sara Tomassetti Claudia Ravaglia Venerino Poletti Bruno Crestani Raphael Borie Caroline Kannengiesser Helen Parfrey Christine Fiddler Doris Rassl Maria Molina-Molina Carlos Machahua Ana Montes Worboys Gunnar Gudmundsson Helgi J Isaksson David J Lederer Anna J Podolanczuk Sydney B Montesi Elisabeth Bendstrup Vivi Danchel Moises Selman Annie Pardo Michael T Henry Michael P Keane Peter Doran Martina Vašáková Martina Sterclova Christopher J Ryerson Pearce G Wilcox Tsukasa Okamoto Haruhiko Furusawa Yasunari Miyazaki Geoffrey Laurent Svetlana Baltic Cecilia Prele Yuben Moodley Barry S Shea Ken Ohta Maho Suzukawa Osamu Narumoto Steven D Nathan Drew C Venuto Merte L Woldehanna Nurdan Kokturk Joao A de Andrade Tracy Luckhardt Tejaswini Kulkarni Francesco Bonella Seamus C Donnelly Aoife McElroy Michelle E Armstong Alvaro Aranda Roberto G Carbone Francesco Puppo Kenneth B Beckman Deborah A Nickerson Tasha E Fingerlin David A Schwartz

Am J Respir Crit Care Med 2019 07;200(2):199-208

1 National Jewish Health, Denver, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201810-1891OCDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635791PMC
July 2019

Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.

Respir Med 2019 07 24;153:44-51. Epub 2019 Apr 24.

Department of Medicine, Cedars-Sinai Medical Center, 87000 Beverly Boulevard, Los Angeles, CA, 90048, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2019.04.016DOI Listing
July 2019

Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: A cohort study.

Respir Med 2019 Jul - Aug;154:1-5. Epub 2019 Jun 4.

Advanced Lung Disease and Transplant Program. Inova Fairfax Hospital, Falls Church, VA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2019.05.020DOI Listing
June 2019

Pulmonary hypertension due to interstitial lung disease.

Curr Opin Pulm Med 2019 Jun 18. Epub 2019 Jun 18.

Inova Fairfax Advanced Lung Disease and Transplant Clinic, Falls Church, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000599DOI Listing
June 2019

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Authors:
Christopher J Rhodes Ken Batai Marta Bleda Matthias Haimel Laura Southgate Marine Germain Michael W Pauciulo Charaka Hadinnapola Jurjan Aman Barbara Girerd Amit Arora Jo Knight Ken B Hanscombe Jason H Karnes Marika Kaakinen Henning Gall Anna Ulrich Lars Harbaum Inês Cebola Jorge Ferrer Katie Lutz Emilia M Swietlik Ferhaan Ahmad Philippe Amouyel Stephen L Archer Rahul Argula Eric D Austin David Badesch Sahil Bakshi Christopher Barnett Raymond Benza Nitin Bhatt Harm J Bogaard Charles D Burger Murali Chakinala Colin Church John G Coghlan Robin Condliffe Paul A Corris Cesare Danesino Stéphanie Debette C Gregory Elliott Jean Elwing Melanie Eyries Terry Fortin Andre Franke Robert P Frantz Adaani Frost Joe G N Garcia Stefano Ghio Hossein-Ardeschir Ghofrani J Simon R Gibbs John Harley Hua He Nicholas S Hill Russel Hirsch Arjan C Houweling Luke S Howard Dunbar Ivy David G Kiely James Klinger Gabor Kovacs Tim Lahm Matthias Laudes Rajiv D Machado Robert V MacKenzie Ross Keith Marsolo Lisa J Martin Shahin Moledina David Montani Steven D Nathan Michael Newnham Andrea Olschewski Horst Olschewski Ronald J Oudiz Willem H Ouwehand Andrew J Peacock Joanna Pepke-Zaba Zia Rehman Ivan Robbins Dan M Roden Erika B Rosenzweig Ghulam Saydain Laura Scelsi Robert Schilz Werner Seeger Christian M Shaffer Robert W Simms Marc Simon Olivier Sitbon Jay Suntharalingam Haiyang Tang Alexander Y Tchourbanov Thenappan Thenappan Fernando Torres Mark R Toshner Carmen M Treacy Anton Vonk Noordegraaf Quinten Waisfisz Anna K Walsworth Robert E Walter John Wharton R James White Jeffrey Wilt Stephen J Wort Delphine Yung Allan Lawrie Marc Humbert Florent Soubrier David-Alexandre Trégouët Inga Prokopenko Richard Kittles Stefan Gräf William C Nichols Richard C Trembath Ankit A Desai Nicholas W Morrell Martin R Wilkins

Lancet Respir Med 2019 Mar 5;7(3):227-238. Epub 2018 Dec 5.

Department of Medicine, Imperial College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30409-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391516PMC
March 2019

Left Ventricular Function Before and After Aerobic Exercise Training in Women With Pulmonary Arterial Hypertension.

J Cardiopulm Rehabil Prev 2019 03;39(2):118-126

Department of Rehabilitation Science, George Mason University, Fairfax, Virginia (Drs Woolstenhulme, Guccione, Herrick, Collins, and Keyser); Rehabilitation Medicine Department, Clinical Research Center, National Institutes of Health, Bethesda, Maryland (Drs Woolstenhulme, Collins, Chan, and Keyser); The Department of Physical Therapy and Health Care Sciences, The George Washington University, Washington, District of Columbia (Dr Woolstenhulme); and Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia (Dr Nathan).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCR.0000000000000397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452473PMC
March 2019

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.

EBioMedicine 2019 Feb 26;40:541-553. Epub 2019 Jan 26.

Genomic Research Alliance for Transplantation (GRAfT), 10 Center Drive, 7S261, Bethesda, MD 20982, United States; Division of Intramural Research, National Heart, Lung and Blood Institute, 10 Center Drive, 7S261, Bethesda, MD 20982, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.12.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412014PMC
February 2019

Pulmonary hypertension in chronic lung disease and hypoxia.

Eur Respir J 2019 Jan 24;53(1). Epub 2019 Jan 24.

University of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig University Giessen and Member of the German Center for Lung Research (DZL), Giessen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01914-2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351338PMC
January 2019

Novel management strategies for idiopathic pulmonary fibrosis.

Expert Rev Respir Med 2018 10 30;12(10):831-842. Epub 2018 Aug 30.

a Transplant Department , Inova Health System , Falls Church , VA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17476348.2018.1
Publisher Site
http://dx.doi.org/10.1080/17476348.2018.1513332DOI Listing
October 2018

Exercise pulmonary haemodynamic response predicts outcomes in fibrotic lung disease.

Eur Respir J 2018 09 27;52(3). Epub 2018 Sep 27.

Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA, USA.

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01015
Publisher Site
http://dx.doi.org/10.1183/13993003.01015-2018DOI Listing
September 2018

Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia.

Eur Respir J 2018 07 4;52(1). Epub 2018 Jul 4.

Inova Fairfax Hospital Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA.

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/lookup/doi/10.1183/13993003.00545
Publisher Site
http://dx.doi.org/10.1183/13993003.00545-2018DOI Listing
July 2018

Single vs. bilateral lung transplantation: when and why.

Curr Opin Organ Transplant 2018 06;23(3):316-323

Inova Lung Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOT.0000000000000527DOI Listing
June 2018

An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.

Expert Opin Emerg Drugs 2018 06 8;23(2):159-172. Epub 2018 May 8.

a Inova Advanced Lung Disease and Lung Transplant program , Falls Church , VA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2018.1471465DOI Listing
June 2018

A 24-Year-Old Woman With Precipitous Respiratory Failure After Lung Transplantation.

Chest 2018 03;153(3):e53-e56

Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00123692173146
Publisher Site
http://dx.doi.org/10.1016/j.chest.2017.08.020DOI Listing
March 2018

The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis.

Ann Am Thorac Soc 2018 01;15(1):3-10

Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/AnnalsATS.201703-244FRDOI Listing
January 2018

A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma.

J Allergy Clin Immunol 2017 12 15;140(6):1716-1718. Epub 2017 Jun 15.

Laboratory of Asthma and Lung Inflammation, Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2017.05.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723231PMC
December 2017

Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary Hypertension.

Chest 2017 11 17;152(5):980-989. Epub 2017 May 17.

Advanced Lung Disease and Transplant Program, INOVA Fairfax Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2017.05.008DOI Listing
November 2017

The Diagnosis and Management of Airway Complications Following Lung Transplantation.

Chest 2017 09 6;152(3):627-638. Epub 2017 Mar 6.

Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2017.02.021DOI Listing
September 2017

Pitfalls in developing new compounds for idiopathic pulmonary fibrosis.

Curr Opin Pulm Med 2017 09;23(5):426-431

aAdvanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VirginiabDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000407DOI Listing
September 2017

Early postoperative management after lung transplantation: Results of an international survey.

Clin Transplant 2017 07 29;31(7). Epub 2017 May 29.

Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.12985DOI Listing
July 2017

Evaluating new treatment options.

Authors:
Steven D Nathan

Am J Manag Care 2017 Jul;23(11 Suppl):S183-S190

View Article

Download full-text PDF

Source
July 2017

Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis.

J Manag Care Spec Pharm 2017 Mar;23(3-b Suppl):S17-S24

5 Interstitial Lung Disease Unit, Royal Brompton Hospital/Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2017.23.3-b.s17DOI Listing
March 2017

Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension.

J Manag Care Spec Pharm 2017 Mar;23(3-b Suppl):S3-S4

3 Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2017.23.3-b.s3DOI Listing
March 2017

Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.

Chest 2017 Jan 20;151(1):204-214. Epub 2016 Aug 20.

Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.08.002DOI Listing
January 2017

Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities.

Lancet Respir Med 2017 01 3;5(1):72-84. Epub 2016 Sep 3.

Advanced Lung Disease and Lung Transplant Clinic, Inova Fairfax Hospital, Falls Church, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(16)30222-3DOI Listing
January 2017

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

Respir Med 2017 01 5;122 Suppl 1:S10-S13. Epub 2016 Nov 5.

Royal Brompton & Harefield, NHS Foundation, London, England, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2016.11.003DOI Listing
January 2017

sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension.

Respir Med 2017 01 14;122 Suppl 1:S28-S34. Epub 2016 Nov 14.

Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Vienna, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2016.11.010DOI Listing
January 2017

Lung transplantation in IIP: A review.

Respirology 2016 10 3;21(7):1173-84. Epub 2015 Dec 3.

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/resp.12691DOI Listing
October 2016

Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function.

Eur Respir J 2016 09 28;48(3):843-51. Epub 2016 Jul 28.

Interstitial Lung Disease Program, Division of Pulmonary, Critical Care, and Sleep Medicine, Dept of Medicine, National Jewish Health, Denver, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01966-2015DOI Listing
September 2016

POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? Yes.

Chest 2016 08 9;150(2):273-5. Epub 2016 Jun 9.

Advanced Lung Disease and Transplant Clinic, Inova Fairfax Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.04.034DOI Listing
August 2016

Rebuttal From Drs King and Nathan.

Chest 2016 08 9;150(2):278. Epub 2016 Jun 9.

Advanced Lung Disease and Transplant Clinic, Inova Fairfax Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.04.035DOI Listing
August 2016

Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.

Respir Med 2016 08 29;117:254-63. Epub 2016 Jun 29.

Inova Advanced Lung Disease Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2016.06.018DOI Listing
August 2016

A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis.

Expert Opin Drug Saf 2016 Jul 26;15(7):975-82. Epub 2016 May 26.

b Department of Internal Medicine , Virginia Commonwealth University, Inova Fairfax Hospital , Falls Church , VA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2016.1187129DOI Listing
July 2016

Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.

Eur Respir J 2016 06;47(6):1615-7

Advanced Lung Disease and Transplant Program, Dept of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00395-2016DOI Listing
June 2016

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis.

Eur Respir J 2016 05 4;47(5):1445-51. Epub 2016 Feb 4.

Advanced Lung Disease and Lung Transplant Program, Dept of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01532-2015DOI Listing
May 2016

Antacid therapy and idiopathic pulmonary fibrosis: cause for heartburn?

Authors:
Steven D Nathan

Lancet Respir Med 2016 05 31;4(5):340-1. Epub 2016 Mar 31.

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Heart and Vascular Institute, VA 22042, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(16)00102-8DOI Listing
May 2016

Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension?

Thorax 2016 Feb 23;71(2):107-9. Epub 2015 Nov 23.

Institute of Cellular Medicine, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

View Article

Download full-text PDF

Source
http://thorax.bmj.com/content/71/2/107.full.pdf
Web Search
http://thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2015-2078
Publisher Site
http://dx.doi.org/10.1136/thoraxjnl-2015-207854DOI Listing
February 2016

Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization.

Respir Med 2015 Dec 6;109(12):1582-8. Epub 2015 Nov 6.

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2015.11.001DOI Listing
December 2015

Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.

BMC Pulm Med 2015 Dec 29;15:167. Epub 2015 Dec 29.

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12890-015-0161-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696269PMC
December 2015

Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosis.

Curr Opin Pulm Med 2015 Sep;21(5):479-89

Advanced Lung Disease and Lung Transplant Clinic, Inova Fairfax Hospital, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000190DOI Listing
September 2015

Organ Donors: Making the Most of What Is Offered.

Chest 2015 Aug;148(2):303-305

Advanced Lung Disease and Lung Transplant Clinic, Inova Fairfax Hospital Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.15-1269DOI Listing
August 2015

Cardiorespiratory function before and after aerobic exercise training in patients with interstitial lung disease.

J Cardiopulm Rehabil Prev 2015 Jan-Feb;35(1):47-55

Department of Rehabilitation Science, George Mason University, Fairfax, VA (Drs Keyser, Woolstenhulme, and Chin); Rehabilitation Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD (Drs Keyser, Chin, Chan, and Woolstenhulme and Mr Drinkard); and Department of Medicine (Drs Nathan, Weir, and Lamberti) and Pulmonary Rehabilitation Center, Inova Fairfax Hospital, Falls Church, VA (Ms Connors).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCR.0000000000000083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276491PMC
July 2015

Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions.

Chest 2015 Jul;148(1):242-252

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Health Systems, Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.14-2475DOI Listing
July 2015

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?

Drug Des Devel Ther 2014 2;8:875-85. Epub 2014 Jul 2.

Advanced Lung Disease Clinic, Inova Fairfax Hospital, Falls Church, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S64907DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085308PMC
May 2015

Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.

Am J Pathol 2015 Apr 7;185(4):943-57. Epub 2015 Feb 7.

Department of Pathology, Stony Brook University School of Medicine, Stony Brook, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2014.12.011DOI Listing
April 2015

Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease.

Respir Med 2015 Apr 7;109(4):517-25. Epub 2015 Feb 7.

Rehabilitation Medicine Department, National Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2015.01.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388636PMC
April 2015

Nebulized medications for the treatment of dyspnea: a literature review.

J Aerosol Med Pulm Drug Deliv 2015 Feb 10;28(1):1-19. Epub 2014 Jun 10.

1 Capital Caring , Falls Church, VA 22042.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jamp.2014.1136DOI Listing
February 2015

The future of lung transplantation.

Authors:
Steven D Nathan

Chest 2015 Feb;147(2):309-316

Lung Transplant and Advanced Lung Disease Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.14-1748DOI Listing
February 2015

Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study.

Chest 2015 Jan;147(1):173-179

Advanced Lung Disease and Transplant Program; University of California at Los Angeles, Los Angeles, CA.. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.13-2424DOI Listing
January 2015

Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Respir Med 2014 Nov 2;108(11):1626-32. Epub 2014 Sep 2.

Advanced Lung Disease and Lung Transplant Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2014.08.009DOI Listing
November 2014

IPF clinical trial design and endpoints.

Curr Opin Pulm Med 2014 Sep;20(5):463-71

aAdvanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia bDepartment of Internal Medicine, Section of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162322PMC
September 2014

Hypersensitivity pneumonitis and pulmonary hypertension: how the breeze affects the squeeze.

Authors:
Steven D Nathan

Eur Respir J 2014 Aug;44(2):287-8

Advanced Lung Disease and Transplant Program, Dept of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00061214DOI Listing
August 2014

Pulmonary hypertension due to fibrotic lung disease: hidden value in a neutral trial.

Am J Respir Crit Care Med 2014 Jul;190(2):131-2

1 Department of Medicine Inova Fairfax Hospital Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201406-1094EDDOI Listing
July 2014

Response.

Chest 2014 Jun;145(6):1440-1441

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.14-0720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042515PMC
June 2014

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

N Engl J Med 2014 May 18;370(22):2083-92. Epub 2014 May 18.

From the University of California, San Francisco, San Francisco (T.E.K.), InterMune, Brisbane (W.Z.B., E.A.F., E.G., D.K.), and Cedars-Sinai Medical Center, Los Angeles (P.W.N.) - all in California; Neumocare, Clínica San Borja, Lima, Peru (S.C.-B.); Alfred Hospital, Melbourne, VIC (I.G.), and Prince Charles Hospital, Brisbane, QLD (P.M.H.) - both in Australia; University of Miami Miller School of Medicine, Miami (M.K.G.); Vanderbilt University Medical Center, Nashville (L.L.); Columbia University Medical Center, New York (D.J.L.); Inova Fairfax Hospital, Falls Church, VA (S.D.N.); Paulista School of Medicine, Federal University of São Paulo, São Paulo (C.A.P.); Medical University of South Carolina, Charleston (S.A.S.); Atlantic Health System-Overlook Medical Center, Summit, NJ (R.S.); and National Jewish Health, Denver (J.J.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1402582DOI Listing
May 2014

The influence of alternative instruction on 6-min walk test distance.

Chest 2013 Dec;144(6):1900-1905

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.13-0287DOI Listing
December 2013

Pulmonary hypertension due to lung disease and/or hypoxia.

Clin Chest Med 2013 Dec 17;34(4):695-705. Epub 2013 Oct 17.

Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccm.2013.08.004DOI Listing
December 2013

Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.

Curr Opin Pulm Med 2013 Sep;19(5):466-73

Fort Belvoir Community Hospital, Pulmonary/Critical Care Medicine, Fort Belvoir, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0b013e328363f460DOI Listing
September 2013

Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension.

Respir Med 2013 May 7;107(5):778-84. Epub 2013 Mar 7.

Center for the Study of Chronic Illness and Disability, College of Health and Human Services, George Mason University, 4400 University Drive, MSN 2G7, Fairfax, VA 22030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2013.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752591PMC
May 2013

Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials.

Am J Respir Crit Care Med 2012 Oct 12;186(8):712-5. Epub 2012 Jul 12.

Respiratory Medicine, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201206-1010PPDOI Listing
October 2012